Lower levels of vWF are associated with lower risk of cardiovascular disease

Lower levels of vWF are associated with lower risk of cardiovascular disease

Abstract Objective The current study was undertaken to prospectively explore whether having low levels of von Willebrand factor (vWF) antigen and vWF activity reduce the risk for cardiovascular disease and death. Methods VWF antigen and vWF activity were measured by enzyme‐linked immunosorbent assay...

Full description

Bibliographic Details
Main Authors:	Pauline C. S. vanParidon, Marina Panova‐Noeva, Rene vanOerle, Andreas Schulz, Jürgen H. Prochaska, Natalie Arnold, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Karl J. Lackner, Hugo tenCate, Philipp S. Wild, Henri M. H. Spronk
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	Research and Practice in Thrombosis and Haemostasis
Subjects:	cardiovascular diseases general population incidence thrombosis von Willebrand factor
Online Access:	https://doi.org/10.1002/rth2.12797

Similar Items

Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
by: T V Antonova, et al.
Published: (2013-12-01)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022-07-01)

Association of Ang-2, vWF, and EVLWI with risk of mortality in sepsis patients with concomitant ARDS: A retrospective study
by: Shuang Ma, et al.
Published: (2020-05-01)

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2017-11-01)

Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background
by: Pauline C. S. van Paridon, et al.
Published: (2022-06-01)

VAS2870 Inhibits Histamine-Induced Calcium Signaling and vWF Secretion in Human Umbilical Vein Endothelial Cells
by: Pavel V. Avdonin, et al.
Published: (2019-02-01)

Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma
by: Samuel Wan Ki Wong, et al.
Published: (2023-09-01)

VWF, Platelets and the Antiphospholipid Syndrome
by: Shengshi Huang, et al.
Published: (2021-04-01)

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
by: Jessica Garcia, et al.
Published: (2020-01-01)

Staphylococcus aureus vWF-binding protein triggers a strong interaction between clumping factor A and host vWF
by: Albertus Viljoen, et al.
Published: (2021-04-01)

Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF
by: Matthias F. Schneider, et al.
Published: (2020-09-01)

SpAD Biofunctionalized Cellulose Acetate Scaffolds Inhibit <i>Staphylococcus aureus</i> Adherence in a Coordinating Function with the von Willebrand A1 Domain (vWF A1)
by: Stefanos Pendas, et al.
Published: (2022-02-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01)

Clinical Application of Factor VIII:C to VWF:Ag Ratio for the Screening of Haemophilia A Carriers
by: Ki-Young Yoo, et al.
Published: (2022-03-01)

ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability
by: Hiroaki Takaya, et al.
Published: (2022-03-01)

Phenotypic and Genotypic Signatures of VWF Exon 18 in Eastern Saudi Patients Previously Diagnosed with Type 1 von Willebrand Disease
by: Alzahrani FM, et al.
Published: (2022-06-01)

The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model
by: Yathreb Asaad, et al.
Published: (2019-07-01)

Expression of vWF in transplanted human lung cancer with the different metastatic potential
by: SI Xiao-li, LI Shuang-yan, GUO Chao, ZHANG Song, ZHANG Li
Published: (2020-03-01)

Distribution and history of extensional stresses on vWF surrogate molecules in turbulent flow
by: Oanh L. Pham, et al.
Published: (2022-01-01)

Adaptive evolution of the venom-targeted vWF protein in opossums that eat pitvipers.
by: Sharon A Jansa, et al.
Published: (2011-01-01)

The Level of vWF Antigen and Coagulation Markers in Hospitalized Patients with Covid-19
by: Al Otair H, et al.
Published: (2021-08-01)

The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients
by: Kiruphagaran Thangaraju, et al.
Published: (2022-01-01)

New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF
by: Zhi-Yan Liu, et al.
Published: (2023-02-01)

Determining the structure of the complex between vWF-A of factor B and CD55
by: Banham, J, et al.
Published: (2008)

Comparison of thrombomodulin, vWF, and ADAMTS13 levels between preeclampsia and normal pregnancy
by: Aisha Ahmad, et al.
Published: (2023-12-01)

Haemostaseological Changes of VWF and FVIII during Pregnancy and the Oestrus Cycle in a Porcine Model of Von Willebrand Disease
by: Rabea Möller, et al.
Published: (2024-02-01)

Platelet accumulation in an endothelium-coated elastic vein valve model of deep vein thrombosis is mediated by GPIbα—VWF interaction
by: Hosam Alden Baksamawi, et al.
Published: (2023-04-01)

A 12.3-kb Duplication Within the VWF Gene in Pigs Affected by Von Willebrand Disease Type 3
by: Stefanie Lehner, et al.
Published: (2018-02-01)

Cigarette Smoking Is Related to Endothelial Dysfunction of Resistance, but Not Conduit Arteries in the General Population—Results From the Gutenberg Health Study
by: Omar Hahad, et al.
Published: (2021-05-01)

1.4 Prognostic Relevance of Augmentation Index in Prevalent Cardiovascular Disease and Total Mortality: Data From the General Population
by: Natalie Arnold, et al.
Published: (2020-02-01)

Mechanical Compression Effects on the Secretion of vWF and IL-8 by Cultured Human Vein Endothelium.
by: Dar Weiss, et al.
Published: (2017-01-01)

Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels
by: Cohen William, et al.
Published: (2011-08-01)

Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study
by: Carmen Escuriola Ettingshausen, et al.
Published: (2022-04-01)

Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report
by: Claire Berger, et al.
Published: (2023-12-01)

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance
by: T. V. Antonova, et al.
Published: (2014-09-01)

Riociguat inhibits ultra‐large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients
by: Takayuki Jujo Sanada, et al.
Published: (2022-10-01)

Study Of Relationship Between Circulating Endothelial Cell Numbers And Plasma VWF Levels With Other Hematologic Findings In Patient With Chronic Lymphocytic Leukemia
by: Samaneh Heidarpourian, et al.
Published: (2016-02-01)

Study Of Relationship Between Circulating Endothelial Cell Numbers And Plasma VWF Levels With Other Hematologic Findings In Patient With Chronic Lymphocytic Leukemia
by: Samaneh Heidarpourian, et al.
Published: (2016-02-01)

An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)
by: Lissitchkov T, et al.
Published: (2020-10-01)